SELLAS Life Sciences Group, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $71.8M | $13.9M | $2.5M | $17.1M | $21.4M | $35.3M | $7.3M | $5.3M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $75.2M | $16.3M | $3.2M | $17.8M | $23.0M | $36.9M | $8.2M | $5.8M |
| Property, Plant & Equipment | — | — | — | — | — | — | — | — |
| Goodwill | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $78.3M | $19.4M | $6.2M | $20.9M | $26.3M | $46.0M | $16.6M | $16.9M |
| Liabilities | ||||||||
| Accounts Payable | $2.9M | $3.5M | $5.6M | $3.4M | $2.1M | $4.7M | $3.9M | $3.8M |
| Total Current Liabilities | $7.0M | $9.5M | $13.7M | $15.5M | $5.0M | $12.3M | $5.3M | $6.0M |
| Long-Term Debt | — | — | — | — | — | — | — | $0 |
| Total Liabilities | $7.5M | $10.0M | $14.2M | $16.1M | $5.9M | $18.1M | $10.5M | $11.7M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-275.0M | $-248.1M | $-217.2M | $-179.9M | $-138.6M | $-117.9M | $-101.1M | $-81.9M |
| Total Stockholders' Equity | $70.9M | $9.5M | $-8.0M | $4.9M | $20.3M | $28.0M | $6.1M | $5.2M |